Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.28B |
| 2 |
Apple
AAPL
|
+$1.23B |
| 3 |
Broadcom
AVGO
|
+$682M |
| 4 |
Amazon
AMZN
|
+$629M |
| 5 |
Palo Alto Networks
PANW
|
+$595M |
Top Sells
| 1 |
Procter & Gamble
PG
|
+$247M |
| 2 |
Cadence Design Systems
CDNS
|
+$160M |
| 3 |
O'Reilly Automotive
ORLY
|
+$155M |
| 4 |
Synopsys
SNPS
|
+$145M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$135M |
Sector Composition
| 1 | Technology | 28.26% |
| 2 | Healthcare | 13.33% |
| 3 | Financials | 12.08% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3226
INmune Bio
INMB
$52.4M
| $1.4M | ﹤0.01% |
154,680
+11,023
| +8% | +$100K |
|
3227
Atossa Therapeutics
ATOS
$106M
| $1.4M | ﹤0.01% |
1,112,612
-98,273
| -8% | -$124K |
|
3228
Century Therapeutics
IPSC
$43.9M
| $1.4M | ﹤0.01% |
443,499
+22,322
| +5% | +$70.5K |
|
3229
Puma Biotechnology
PBYI
$229M
| $1.4M | ﹤0.01% |
396,396
+4,774
| +1% | +$16.9K |
|
3230
Saga Communications
SGA
$77.5M
| $1.4M | ﹤0.01% |
65,455
+12,668
| +24% | +$271K |
|
|
SEEL
3231
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $1.39M | ﹤0.01% |
304
+8
| +3% | +$36.7K |
|
3232
Hurco Companies Inc
HURC
$112M
| $1.37M | ﹤0.01% |
63,496
+5,376
| +9% | +$116K |
|
|
RDNW
3233
RideNow Group, Inc. Class B Common Stock
RDNW
$154M
| $1.37M | ﹤0.01% |
111,134
-102,790
| -48% | -$1.27M |
|
3234
Foster
FSTR
$284M
| $1.37M | ﹤0.01% |
96,093
+582
| +0.6% | +$8.31K |
|
3235
Black Diamond Therapeutics
BDTX
$192M
| $1.37M | ﹤0.01% |
271,207
+779
| +0.3% | +$3.93K |
|
3236
Provident Bancorp
PVBC
$226M
| $1.37M | ﹤0.01% |
165,264
-130,333
| -44% | -$1.08M |
|
3237
AXT Inc
AXTI
$156M
| $1.37M | ﹤0.01% |
397,707
-400,253
| -50% | -$1.38M |
|
|
LTCH
3238
DELISTED
Latch, Inc. Common Stock
LTCH
| $1.37M | ﹤0.01% |
984,252
-986,479
| -50% | -$1.37M |
|
3239
Orchestra BioMed
OBIO
$141M
| $1.36M | ﹤0.01% |
194,756
+69,750
| +56% | +$488K |
|
|
LENZ
3240
LENZ Therapeutics
LENZ
$1.19B
| $1.35M | ﹤0.01% |
74,024
+38,684
| +109% | +$704K |
|
|
KC
3241
Kingsoft Cloud Holdings
KC
$4.58B
| $1.34M | ﹤0.01% |
219,466
-46,798
| -18% | -$285K |
|
3242
SWK Holdings
SWKH
$178M
| $1.34M | ﹤0.01% |
100,685
+2,245
| +2% | +$29.8K |
|
3243
Equinor
EQNR
$61.1B
| $1.34M | ﹤0.01% |
45,714
| – | – |
|
3244
Cytosorbents Corp
CTSO
$59.3M
| $1.33M | ﹤0.01% |
371,708
| – | – |
|
3245
Standard BioTools
LAB
$489M
| $1.33M | ﹤0.01% |
687,946
-26,101
| -4% | -$50.4K |
|
3246
Stratasys
SSYS
$838M
| $1.33M | ﹤0.01% |
74,745
+6,862
| +10% | +$122K |
|
|
AVDL
3247
Avadel Pharmaceuticals
AVDL
$1.54B
| $1.33M | ﹤0.01% |
80,402
+399
| +0.5% | +$6.58K |
|
3248
MindMed
MNMD
$734M
| $1.32M | ﹤0.01% |
371,010
+30,955
| +9% | +$111K |
|
3249
Jasper Therapeutics
JSPR
$41.9M
| $1.32M | ﹤0.01% |
96,550
-10,481
| -10% | -$144K |
|
3250
ReposiTrak
TRAK
$306M
| $1.32M | ﹤0.01% |
131,080
+16,374
| +14% | +$165K |
|